Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1980 Nov;10(5):439-42.
doi: 10.1111/j.1365-2125.1980.tb01785.x.

Oxyfederine and propranolol--a controlled trial in angina pectoris

J Whittington, E B Raftery
Clinical Trial

Oxyfederine and propranolol--a controlled trial in angina pectoris

J Whittington et al. Br J Clin Pharmacol. 1980 Nov.

Abstract

1 A double-blind-crossover randomised trial was performed to compare the effects of oxyfedrine (maximum dose 32 mg three times daily), propranolol (maximum dose 120 mg three times daily) and placebo in 30 patients with chronic stable angina pectoris. Assessment was by means of symptom level, ECG responses to graded exercise and haematological and biochemical investigation. 2 Oxyfedrine and propranolol resulted in similar significant improvements in symptom level (P < 0.05 in both cases), and ST index (propranolol P < 0.02; oxyfedrine P < 0.05). Neither drug produced any significant changes in haematologaical or biochemical investigations and only infrequent minor side effects were noted. 3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.

PubMed Disclaimer

References

    1. Med Welt. 1966 Sep 3;(36):1910-5 - PubMed
    1. N Engl J Med. 1966 Nov 17;275(20):1106-12 contd - PubMed
    1. Arztl Forsch. 1967 Sep 10;21(9):354-8 - PubMed
    1. Arzneimittelforschung. 1969 Sep;19(9):1562-6 - PubMed
    1. Circulation. 1971 Jan;43(1):45-57 - PubMed

Publication types